Organization of Urological and Oncourological Care for Patients in a Pandemic of COVID-19: Overcoming Existing Limitations

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The new coronavirus infection pandemic has certainly changed all spheres of human activity, the healthcare system was completely transformed and reassignment in a short time. The built model of a personalized approach to each patient was replaced by the provision of health services to groups of patients with similar symptoms of the disease and severity, and conditions not associated with coronavirus infection, anyway, took a back seat. Since the announcement of the COVID-19 pandemic, the main human and material resources have been directed at combating the new infection. To date, almost every country has cases of coronavirus infection. The planned surgical care was temporarily stopped, what could not but affect the outcomes of diseases. A special category of patients is represented by patients with diagnosed malignant neoplasms, the delay in treatment of which can significantly reduce the life expectancy and/or quality of life. The current state of the problem served as a catalyst for the development of telemedicine technologies, which simplified communication in the patient-physician and physician-physician relationship. Urinary tract infections are one of the most common reasons for visiting a urologist, which implies the prescription of antibacterial drugs. However, in a pandemic, remote prescription of these drugs is limited by the lack of face-to-face specialist consultations. This enabled make it possible to use drugs based on bacteriophages. Patient management problems were solved by using distance counseling techniques. In this article we present an algorithm for providing urological and oncourological care to patients in the context of the COVID-19 pandemic, as well as an overview of the existing world practice in the implementation of telemedicine consultations in the current epidemiological situation.

Full Text

Restricted Access

About the authors

Alexandr O. Vasilyev

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov; State-financed Institution of Moscow city "Scientific Research Institute of Healthcare Organization and Medical Management of Moscow Department of Healthcare"; City Clinical Hospital named after S.I. Spasokukotsky

Email: alexvasilyev@me.com
ORCID iD: 0000-0001-5468-0011
SPIN-code: 1886-1537

MD, PhD, Assistant

Russian Federation, Moscow; Moscow; Moscow

Raisa D. Ruvinova

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: luch2000mira@mail.ru
ORCID iD: 0000-0003-4622-9081
SPIN-code: 6093-0442

Student

Russian Federation, Moscow

Konstantin B. Kolotarev

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov; City Clinical Hospital named after S.I. Spasokukotsky

Email: kolontarev@me.com
ORCID iD: 0000-0003-4511-5998
SPIN-code: 2352-1103

MD, PhD, Professor

Russian Federation, Moscow; Moscow

Natalia A. Sazonova

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Author for correspondence.
Email: kalinina@outlook.com
ORCID iD: 0000-0003-1673-1089
SPIN-code: 1238-6260

Clinical Resident

Russian Federation, 21/2 Vucheticha str., 127206, Moscow

Alexandr V. Govorov

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov; City Clinical Hospital named after S.I. Spasokukotsky

Email: dr.govorov@gmail.com
ORCID iD: 0000-0003-3299-0574
SPIN-code: 6968-1187

MD, PhD, Professor

Russian Federation, Moscow; Moscow

Arseny A. Shiraev

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov; City Clinical Hospital named after S.I. Spasokukotsky

Email: phd.shiryaev@gmail.com
ORCID iD: 0000-0003-0680-9460
SPIN-code: 2126-4319

PhD Student

Russian Federation, Moscow; Moscow

Dmitriy Y. Pushkar

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov; City Clinical Hospital named after S.I. Spasokukotsky

Email: pushkardm@mail.ru
ORCID iD: 0000-0002-6096-5723
SPIN-code: 8221-8306

MD, PhD, Professor, Academician of the RAS

Russian Federation, Moscow; Moscow

References

  1. Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol. 2020;38(1):10–18. doi: https://doi.org/10.12932/AP-200220-0773
  2. Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol. 2016;3:237–261. doi: https://doi.org/10.1146/annurev-virology-110615-042301
  3. Kupferschmidt K, Cohen J. China’s COVID-19 strategy work elsewhere? Science. 2020;367:1061–1062. doi: https://doi.org/10.1126/science.367.6482.1061
  4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5
  5. Jin Y, Yang H, Ji W, et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020;12(4):372. doi: https://doi.org/10.3390/v12040372
  6. Shigemura J, Ursano RJ, Morganstein JC, et al. Public responses to the novel 2019 coronavirus (2019 — nCoV): mental health consequences and target populations. Psychiatry Clin Neurosci. 2020;74(4):281–282. doi: https://doi.org/10.1111/pcn.12988
  7. Rajkumar P. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020;52:102066. doi: https://doi.org/10.1016/j.ajp.2020.102066
  8. Neto MLR, Souza RI, et al. When basic supplies are missing, what to do? Specific demands of the local street population in times of coronavirus – a concern of social psychiatry. Psychiatry Research. 2020;288:112939. doi: https://doi.org/10.1016/j.psychres.2020.112939
  9. Ficarra V, Novara G, Abrate A, et al. Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol. 2020;72(3):369–375. doi: https://doi.org/10.23736/S0393-2249.20.03846-1
  10. Naspro R, Da Pozzo LF. Urology in the time of corona. Nat Rev Urol. 2020;17(5):251–253. doi: https://doi.org/10.1038/s41585-020-0312-1
  11. Blozik E, Sommer-Meyer C, Cerezo M, von Overbeck J. Effectiveness and safety of telemedical management in uncomplicated urinary tract infections. J Telemed Telecare. 2011;17(2):78–82. doi: https://doi.org/10.1258/jtt.2010.100406
  12. Rastogi R, Martinez KA, Gupta N, et al. Management of urinary tract infections in direct to consumer telemedicine. J Gen Intern Med. 2020;35(3):643–648. doi: https://doi.org/10.1007/s11606-019-05415-7
  13. Leitner L, Sybesma W, Chanishvili N, et al. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial. BMC Urol. 2017;17(1):90. doi: https://doi.org/10.1186/s12894-017-0283-6
  14. Васильев А.О., Сазонова Н.А., Мельников В.Д., и др. Опыт применения комплексного антибактериального и обезболивающего препарата на основе бактериофагов в гелевой форме у женщин, перенесших различные инструментальные и лечебно-диагностические манипуляции // Гинекология. — 2020. — Т. 22. — № 3. — C. 42–48. [Vasil’ev AO, Sazonova NA, Mel’nikov VD, et al. The experience of using a bacteriophages-based complex antibacterial and analgesic drug in gel formulation in women who underwent various instrumental and diagnostic and treatment interventions. Ginekologiya. 2020;22(3):42–48 (In Russ.)]. doi: https://doi.org/10.26442/20795696.2020.3.200199
  15. Polinski JM, Barker T, Gagliano N, et al. Patients’ Satisfaction with and Preference for Telehealth Visits. J Gen Intern Med. 2016;31(3):269–275. doi: https://doi.org/10.1007/s11606-015-3489-x
  16. Fiorini RA, De Giacomo P, L’Abate L. Towards Resilient Telehealth Support for Clinical Psychiatry and Psychology: A Strategic Review. Stud Health Technol Inform. 2015;213:275–278. doi: https://doi.org/10.3233/978-1-61499-538-8-275
  17. Vieta E, Pérez V, Arango C. Psychiatry in the aftermath of COVID-19. Rev Psiquiatr Salud Ment. 2020;13(2):105–110. doi: https://doi.org/10.1016/j.rpsm.2020.04.004
  18. Boehm K, Ziewers S, Brandt MP, et al. Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients’ Perspective. Eur Urol. 2020;78(1):16–20. doi: https://doi.org/10.1016/j.eururo.2020.04.055
  19. Аполихин О.И., Сивков А.В., Владзимирский А.В., и др. Применение телемедицинской веб-платформы nethealth.ru как инструмента поддержки клинических решений в урологии // Экспериментальная и клиническая урология. — 2015. — № 3. — С. 4–10. [Apolihin OI, Sivkov AV, Vladzimirskij AV, et al. Use of telemedicine web platform NetHealth.ru as an instrument of a clinical support in urology. 2015;3:4–10 (In Russ.)]
  20. Novara G, Checcucci E, Crestani A, et al. Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful during and after the COVID-19 Pandemic? Eur Urol. 2020;S0302-2838(20):30454-1. doi: https://doi.org/10.1016/j.eururo.2020.06.025

Statistics

Views

Abstract: 432

PDF (Russian): 1

Article Metrics

Metrics Loading ...

Dimensions

PlumX


Copyright (c) 2020 Russian academy of sciences



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies